Yoshiaki Kanemoto Selected Research

Prostate-Specific Antigen (Semenogelase)

1/2021

Profiling of Androgen-Dependent Enhancer RNAs Expression in Human Prostate Tumors: Search for Malignancy Transition Markers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiaki Kanemoto Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2021
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
2	Thiamine Deficiency 09/2021 - 03/2020
2	Rectal Neoplasms (Rectal Cancer) 06/2021 - 12/2019
2	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 01/2019
2	Cholangitis 03/2019 - 11/2015
1	Chronic Disease (Chronic Diseases) 08/2023
1	Osteoporosis 08/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2022
1	Internal Hernia 08/2022
1	Folic Acid Deficiency (Folic Acid Deficiencies) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Pancytopenia 01/2022
1	Edema (Dropsy) 12/2021
1	Dysphonia (Spastic Dysphonia) 12/2021
1	Hyperammonemia 06/2021
1	Adenoma (Adenomas) 06/2021
1	Diverticulitis 01/2021
1	Carcinogenesis 01/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2020
1	Cognitive Dysfunction 03/2020
1	Colitis 01/2020
1	Lymphatic Metastasis 03/2019
1	Fatigue 03/2019
1	Stomach Neoplasms (Stomach Cancer) 03/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Cholangiocarcinoma 11/2015

Drug/Important Bio-Agent (IBA)

4	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2021
3	ChromatinIBA 01/2023 - 01/2022
3	AndrogensIBA 01/2023 - 01/2021
2	Enhancer RNAsIBA 01/2023 - 01/2021
2	LigandsIBA 01/2023 - 01/2022
2	Thiamine (Aneurin)FDA Link 09/2021 - 03/2020
1	CalciumIBA 08/2023
1	Estrogens (Estrogen)FDA Link 08/2023
1	Estrogen ReceptorsIBA 08/2023
1	Vitamin D FDA LinkGeneric 08/2023
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2023
1	bicalutamide (Casodex)FDA LinkGeneric 01/2023
1	Androgen Receptor AntagonistsIBA 01/2023
1	hydroxide ionIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Testosterone CongenersIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 12/2021
1	afliberceptIBA 12/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2021
1	NivolumabIBA 12/2021
1	Panitumumab (Vectibix)FDA Link 12/2021
1	A-factor (Streptomyces)IBA 12/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2020
1	Serum AlbuminIBA 03/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2019
1	Methotrexate (Mexate)FDA LinkGeneric 03/2019

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Therapeutics 01/2023 - 06/2021
2	Gastrectomy 01/2022 - 03/2019
1	Castration 01/2023
1	Laparotomy 08/2022
1	Aftercare (After-Treatment) 01/2022
1	Chemoradiotherapy 06/2021
1	Appendectomy 06/2021
1	Conservative Treatment 01/2021
1	Ileostomy 01/2020
1	Neoadjuvant Therapy 12/2019
1	Combination Drug Therapy (Combination Chemotherapy) 01/2019
1	Stents 11/2015